FDA advisers vote against sleep peptide over safety and health claim concerns

The FDA's advisory committee has voted against allowing a sleep-related peptide to be used in compounded preparations, citing safety and health claim concerns. The two-day meeting examined seven peptides that have grown popular in wellness circles, debating whether they should be permitted for compounding. Regulators expressed doubts about both the safety profiles and the validity of health claims made for these substances.

More on this topic

🏥 Health RFK Jr.-stacked FDA panel votes to ease peptide manufacturing restrictions Ars Technica · 12h ago 🏥 Health FDA considers allowing compounding pharmacies to produce BPC-157 and TB-500 peptides NYT Health · 1d ago 🏥 Health FDA Panel Endorses Unproven Peptides Including Joe Rogan's 'Wolverine Stack' Wired · 1d ago

More on this topic

🏥 Health RFK Jr.-stacked FDA panel votes to ease peptide manufacturing restrictions Ars Technica · 12h ago 🏥 Health FDA considers allowing compounding pharmacies to produce BPC-157 and TB-500 peptides NYT Health · 1d ago 🏥 Health FDA Panel Endorses Unproven Peptides Including Joe Rogan's 'Wolverine Stack' Wired · 1d ago